Humana Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
30 Apr
Humana Inc reports results for the quarter ended March 31 - Earnings Summary
  • Humana Inc HUM.N reported quarterly adjusted earnings of $11.58​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $7.23. The mean expectation of twenty four analysts for the quarter was for earnings of $10.07 per share. Wall Street expected results to range from $8.53 to $10.92 per share.

  • Revenue rose 9.5% to $32.11 billion from a year ago; analysts expected $32.22 billion.

  • Humana Inc's reported EPS for the quarter was $10.30​.

  • The company reported quarterly net income of $1.24 billion.

  • Humana Inc shares had fallen by 2.0% this quarter and gained 2.2% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 44.7% in the last three months.​

  • In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 7 "strong buy" or "buy," 19 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the managed healthcare peer group is also "hold"

  • Wall Street's median 12-month price target for Humana Inc is $300.00

This summary was machine generated from LSEG data April 30 at 11:01 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Mar. 31 2025

10.07

11.58

Beat

Dec. 31 2024

-2.16

-2.16

Met

Sep. 30 2024

3.40

4.16

Beat

Jun. 30 2024

5.85

6.96

Beat

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10